Novo Nordisk's long-acting insulin Tresiba is set to gain new ... where biosimilars are driving down prices of Sanofi’s drug. Tresiba was approved by the FDA in 2015 on the basis of top-line ...

The company also blamed pharmacy managers and insurers who limited access to Levemir on drug ... price of Tresiba. "We have vigorously advocated for universal access to affordable insulin products ...

Crucially, the long-acting insulin was no worse than Tresiba when it came to rates of ... versus 0.27 events for the once-daily drug. Novo Nordisk said that if approved for use, insulin icodec ...